
Company Number
06991109
Next Accounts
Sep 2025
Shareholders
mr adrian ford
dr alexander emodi
View AllGroup Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
st stephens house arthur road, windsor, berkshire, SL4 1RU
Website
www.int2med.comPomanda estimates the enterprise value of INT2MED LIMITED at £477.5k based on a Turnover of £550.9k and 0.87x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INT2MED LIMITED at £0 based on an EBITDA of £-3.5k and a 4.92x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INT2MED LIMITED at £453.9k based on Net Assets of £230.3k and 1.97x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Int2med Limited is a live company located in berkshire, SL4 1RU with a Companies House number of 06991109. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in August 2009, it's largest shareholder is mr adrian ford with a 37.5% stake. Int2med Limited is a established, small sized company, Pomanda has estimated its turnover at £550.9k with healthy growth in recent years.
Pomanda's financial health check has awarded Int2Med Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
7 Weak
Size
annual sales of £550.9k, make it smaller than the average company (£17.9m)
- Int2med Limited
£17.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a faster rate (6.2%)
- Int2med Limited
6.2% - Industry AVG
Production
with a gross margin of 37.4%, this company has a comparable cost of product (37.4%)
- Int2med Limited
37.4% - Industry AVG
Profitability
an operating margin of -1.3% make it less profitable than the average company (5.9%)
- Int2med Limited
5.9% - Industry AVG
Employees
with 4 employees, this is below the industry average (89)
4 - Int2med Limited
89 - Industry AVG
Pay Structure
on an average salary of £49.8k, the company has an equivalent pay structure (£49.8k)
- Int2med Limited
£49.8k - Industry AVG
Efficiency
resulting in sales per employee of £137.7k, this is less efficient (£181.5k)
- Int2med Limited
£181.5k - Industry AVG
Debtor Days
it gets paid by customers after 63 days, this is later than average (50 days)
- Int2med Limited
50 days - Industry AVG
Creditor Days
its suppliers are paid after 7 days, this is quicker than average (35 days)
- Int2med Limited
35 days - Industry AVG
Stock Days
it holds stock equivalent to 176 days, this is more than average (95 days)
- Int2med Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 35 weeks, this is more cash available to meet short term requirements (11 weeks)
35 weeks - Int2med Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 28.2%, this is a lower level of debt than the average (41.9%)
28.2% - Int2med Limited
41.9% - Industry AVG
Int2Med Limited's latest turnover from December 2023 is estimated at £550.9 thousand and the company has net assets of £230.3 thousand. According to their latest financial statements, Int2Med Limited has 4 employees and maintains cash reserves of £43.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 6 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 11,506 | 255 | 767 | 1,418 | 2,440 | 6,646 | 18,219 | 16,348 | 3,128 | 879 | 879 | 452 | 207 | ||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 11,506 | 255 | 767 | 1,418 | 2,440 | 6,646 | 18,219 | 16,348 | 3,128 | 879 | 879 | 452 | 207 | ||
Stock & work in progress | 166,676 | 165,582 | 164,539 | 163,756 | 187,942 | 318,425 | 282,043 | 201,722 | 228,510 | 59,271 | 59,271 | 41,680 | 63,645 | 19,992 | 9,460 |
Trade Debtors | 95,810 | 152,070 | 91,833 | 61,778 | 44,648 | 97,011 | 98,116 | 76,221 | 100,360 | 55,118 | 55,118 | 78,281 | 34,880 | 22,282 | 2,144 |
Group Debtors | |||||||||||||||
Misc Debtors | 3,000 | 3,000 | 3,736 | 181 | 2,036 | 16,888 | 12,589 | 820 | |||||||
Cash | 43,931 | 38,701 | 45,648 | 85,647 | 17,614 | 4,175 | 2,271 | 40,375 | 98,698 | 30,977 | 30,977 | 78,971 | 6,212 | 7,677 | |
misc current assets | |||||||||||||||
total current assets | 309,417 | 359,353 | 305,756 | 311,362 | 252,240 | 436,499 | 382,430 | 330,907 | 427,568 | 145,366 | 145,366 | 198,932 | 105,557 | 49,951 | 11,604 |
total assets | 320,923 | 359,608 | 306,523 | 312,780 | 254,680 | 443,145 | 400,649 | 347,255 | 430,696 | 146,245 | 146,245 | 199,384 | 105,764 | 49,951 | 11,604 |
Bank overdraft | |||||||||||||||
Bank loan | 10,240 | 10,240 | |||||||||||||
Trade Creditors | 7,296 | 19,419 | 17,580 | 5,363 | 15,830 | 151,853 | 165,132 | 114,158 | 258,023 | 53,712 | 53,712 | 81,939 | 83,275 | 58,016 | 19,690 |
Group/Directors Accounts | |||||||||||||||
other short term finances | 6,826 | 50,000 | |||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 47,525 | 57,210 | 35,247 | 33,920 | 28,102 | 55,196 | 42,983 | 58,643 | |||||||
total current liabilities | 65,061 | 86,869 | 59,653 | 89,283 | 43,932 | 207,049 | 208,115 | 172,801 | 258,023 | 53,712 | 53,712 | 81,939 | 83,275 | 58,016 | 19,690 |
loans | 22,695 | 32,935 | 43,175 | ||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 7,691 | 8,747 | 3,754 | ||||||||||||
provisions | 2,877 | 145 | 270 | 464 | 1,263 | 3,462 | 3,270 | 7,691 | |||||||
total long term liabilities | 25,572 | 32,935 | 43,320 | 270 | 464 | 1,263 | 3,462 | 3,270 | 7,691 | 7,691 | 8,747 | 3,754 | |||
total liabilities | 90,633 | 119,804 | 102,973 | 89,553 | 44,396 | 208,312 | 211,577 | 176,071 | 258,023 | 61,403 | 61,403 | 90,686 | 83,275 | 61,770 | 19,690 |
net assets | 230,290 | 239,804 | 203,550 | 223,227 | 210,284 | 234,833 | 189,072 | 171,184 | 172,673 | 84,842 | 84,842 | 108,698 | 22,489 | -11,819 | -8,086 |
total shareholders funds | 230,290 | 239,804 | 203,550 | 223,227 | 210,284 | 234,833 | 189,072 | 171,184 | 172,673 | 84,842 | 84,842 | 108,698 | 22,489 | -11,819 | -8,086 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 3,950 | 512 | 1,072 | 1,364 | 6,236 | 13,322 | 13,836 | 8,733 | 1,092 | 481 | 278 | 103 | |||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | 1,094 | 1,043 | 783 | -24,186 | -130,483 | 36,382 | 80,321 | -26,788 | 169,239 | 17,591 | 17,591 | -21,965 | 43,653 | 10,532 | 9,460 |
Debtors | -56,260 | 59,501 | 33,610 | 15,275 | -67,215 | 15,783 | 9,306 | -11,550 | 45,242 | -23,163 | -23,163 | 42,581 | 13,418 | 20,138 | 2,144 |
Creditors | -12,123 | 1,839 | 12,217 | -10,467 | -136,023 | -13,279 | 50,974 | -143,865 | 204,311 | -28,227 | -28,227 | -1,336 | 25,259 | 38,326 | 19,690 |
Accruals and Deferred Income | -9,685 | 21,963 | 1,327 | 5,818 | -27,094 | 12,213 | -15,660 | 58,643 | |||||||
Deferred Taxes & Provisions | 2,877 | -145 | -125 | -194 | -799 | -2,199 | 192 | 3,270 | -7,691 | 7,691 | |||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 10,240 | ||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | -6,826 | -43,174 | 50,000 | ||||||||||||
Long term loans | -10,240 | -10,240 | 43,175 | ||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -8,747 | -1,056 | 8,747 | -3,754 | 3,754 | ||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 5,230 | -6,947 | -39,999 | 68,033 | 13,439 | 1,904 | -38,104 | -58,323 | 67,721 | -47,994 | -47,994 | 72,759 | -1,465 | 7,677 | |
overdraft | |||||||||||||||
change in cash | 5,230 | -6,947 | -39,999 | 68,033 | 13,439 | 1,904 | -38,104 | -58,323 | 67,721 | -47,994 | -47,994 | 72,759 | -1,465 | 7,677 |
Perform a competitor analysis for int2med limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in SL4 area or any other competitors across 12 key performance metrics.
INT2MED LIMITED group structure
Int2Med Limited has no subsidiary companies.
Ultimate parent company
INT2MED LIMITED
06991109
Int2Med Limited currently has 2 directors. The longest serving directors include Dr Alexander Emodi (Feb 2010) and Mr Adrian Ford (Apr 2010).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Alexander Emodi | England | 67 years | Feb 2010 | - | Director |
Mr Adrian Ford | England | 58 years | Apr 2010 | - | Director |
P&L
December 2023turnover
550.9k
-26%
operating profit
-7.4k
0%
gross margin
37.4%
-3.38%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
230.3k
-0.04%
total assets
320.9k
-0.11%
cash
43.9k
+0.14%
net assets
Total assets minus all liabilities
company number
06991109
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
August 2009
age
16
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
WINDSOR ACCOUNTANCY LTD
auditor
-
address
st stephens house arthur road, windsor, berkshire, SL4 1RU
Bank
HSBC BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to int2med limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INT2MED LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|